RECURRENT CHRONIC LYMPHOID LEUKEMIA

Clinical trials for RECURRENT CHRONIC LYMPHOID LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT CHRONIC LYMPHOID LEUKEMIA trials appear

Sign up with your email to follow new studies for RECURRENT CHRONIC LYMPHOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug combo tested for Tough-to-Treat leukemia

Disease control Ongoing

This early-stage study is testing whether adding an experimental drug called ACY-1215 to existing leukemia medications (ibrutinib or idelalisib) is safe and tolerable for adults with chronic lymphocytic leukemia (CLL) that has returned after prior treatment. The main goal is to f…

Matched conditions: RECURRENT CHRONIC LYMPHOID LEUKEMIA

Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control

Last updated Mar 27, 2026 12:41 UTC

RECURRENT CHRONIC LYMPHOID LEUKEMIA

Get alerted when new RECURRENT CHRONIC LYMPHOID LEUKEMIA trials appear

New drug combo tested for Tough-to-Treat leukemia